saw palmetto berry and Reduced AUASI Score

Doses used in studies

mg/day: 160 (median 160, IQR 160–160) — 1 study

Time to effect

Median: 12.2 months · IQR 12.2 months–12.2 months · Range 12.2 months–12.2 months — Reported in 1 of 1 study

Safety in these studies

Overall tolerabilityNo significant difference
The incidence of side effects was similar in the two groups.
from: Saw palmetto for benign prostatic hyperplasia.

1 of 1 paper

Saw palmetto for benign prostatic hyperplasia.

2006-02-09
RCT · n = 225
The New England journal of medicine 354(6)
- Stephen Bent
- Christopher Kane
- Katsuto Shinohara
- John Neuhaus
- Esther S Hudes
- Harley Goldberg
- Andrew L Avins

PubMed: 16467543
DOI: 10.1056/nejmoa053085

6 Insights on

Reduced AUASI Score

High evidence
Large Human Trial
Highly Cited
Clinical

There was no significant difference between the saw palmetto and placebo groups in the change in AUASI scores (mean difference, 0.04 point; 95 percent confidence interval, -0.93 to 1.01)

Effect: Neutral
Effect size: Small
Significant: No
Dose: 160 mg twice a day